Industry-Academic collaborations for Investigators and Graduate Students March 7, 2014
Friday, March 7, 2014 from 12:00 PM to 1:00 PM (EST)
San Francisco, California
London, United Kingdom
Practical Knowledge Series Lunch Seminar
Collaborating with Industry
March 7, 2014
Industry collaborations play an increasingly important role in academic research and with good reason: Industry can provide tangible resources such as dollars, materials, equipment and expertise, in addition to intangible benefits that include consideration of different questions and approaches, new relationships, and advancement of science.
There are different types of collaborations: Funded and documented, unfunded and documented, unfunded and undocumented. They are between people but also between institutions, each with interests to protect. Publications, patents, and commercialization potential can be enhanced or diminished, depending upon how the collaboration is structured. It is to every academic researcher's advantage to learn the elements of a good collaboration, regardless of how formal or informal it is!
David P. Hesson, Ph.D.
Founder, SternGreene, Inc. & RiboNova, Inc.
Visiting Scholar, University of Pennsylvania Medical School
President, DP Hesson Consulting
Maureen O’Leary, Ph.D.
Director, Technology Transfer at Monell Center
Karen J. Hanson, Ph.D.
Executive Director, BioStrategy Partners
About our Panelists:
Dave Hesson has thirty years of experience in the discovery and development of pharmaceuticals, in startups, small pharma, CROs and large pharma. Currently involved with two start-up companies that he founded, he’s also a visiting scholar in the laboratory of Professor Mark I. Greene at Penn where he provides drug development strategy and medicinal chemistry support for an ongoing research project. Dave has his own consulting firm which provides research planning and CMC drug development advice for early stage pharmaceutical and biotech startups. His Ph.D. in Chemistry is from MIT.
Maureen O’Leary has extensive experience in moving technologies from the laboratory to commercial environments, including evaluating, selecting, marketing and licensing emerging technologies. She is Director of Technology Transfer at the Monell Center in University City. She was Program Director at BioStrategy Partners where she managed the Diligence Program for start-up companies and the Commercialization Germinator for academic inventions. She was Director, Start-Up Business Development at Penn’s Center for Technology Transfer. Her Ph.D. in Physics is from Penn.